Feb 11, 2018
Pharmaceutical Executive
In this Q&A, Richard Lajoie, the new head of Valeant Canada, shares his main priorities for the business, including growing its domestic manufacturing as a key cog globally.
Jan 12, 2018
Pharmaceutical Executive
Bruno Strigini, CEO of Novartis Oncology, talks about the company’s pioneering path in cancer and the related broader issues such as pricing and value and new innovations in cancer science.
Jan 10, 2018
Tracy Rockney and Rob Merrill talk about their free regulatory compliance and information platform MyIndago, and why they think the industry needs it now.
Jan 09, 2018
A quick-fire interview with J&J’s Joanne Waldstreicher about the company’s “Advancing the Safe Use of Healthcare Products QuickFire Challenge”.
Jan 04, 2018
Pharmaceutical Executive
Julia Cheek recently landed in the television history books when she accepted a $1 million offer on the TV show “Shark Tank," the largest valuation for a solo female entrepreneur in the show’s history.
Jan 02, 2018
Sean McCarthy, President & CEO of CytomX, outlines the company’s journey from university startup to rising star of the immuno-oncology space.
Dec 22, 2017
Kilian Weiss talks to Pharm Exec about the modern challenges of identifying KOLs in oncology, and why technology can offer a solution to this vital process.
Nov 15, 2017
Andrew Lane, EVP, Established Pharmaceuticals at Abbott, tells Pharm Exec how understanding emerging market dynamics can explain why branded generic medicines are important.
Nov 13, 2017
Mark Reisenauer, SVP, Oncology Business Unit at Astellas, tells PharmExec about the development and objectives of the Astellas Oncology C3 Prize.
Nov 12, 2017
Prognos CEO Sundeep Bhan talks about how the company’s unique offering will reach beyond life sciences as the long-promised benefits of AI become reality.
lorem ipsum